Research and Markets has announced the addition of the "Glioblastoma Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Glioblastoma Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Glioblastoma market. It covers emerging therapies for Glioblastoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Glioblastoma pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Glioblastoma pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Glioblastoma pipeline products by the company.

Short-term Launch Highlights:

Find out which Glioblastoma pipeline products will be launched in the US and Ex-US till 2020.

Summary:

  • Glioblastoma phase 3 clinical trial pipeline products
  • Glioblastoma phase 2 clinical trial pipeline products
  • Glioblastoma phase 1 clinical trial pipeline products
  • Glioblastoma preclinical research pipeline products
  • Glioblastoma discovery stage pipeline products
  • Glioblastoma pipeline products short-term launch highlights

Key Topics Covered:

1. Glioblastoma Pipeline by Stages

2. Glioblastoma Pipeline by Drug Class

3. Glioblastoma Pipeline by Company

4. Glioblastoma Phase 3 Clinical Trial Insights

5. Glioblastoma Phase 2 Clinical Trial Insights

6. Glioblastoma Phase 1 Clinical Trial Insights

7. Glioblastoma Preclinical Research Insights

8. Glioblastoma Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/9cgxtj/glioblastoma